Background: De novo Crohn's disease (CD) of the neo-small intestine in ulcerative colitis (UC) patients after total proctocolectomy (TPC) is a new disease entity, which may persist even after a secondary diverting permanent ileostomy for pouch failure. We sought to compare outcomes of primary ileostomy (PI, i.e. stoma created after colectomy without trying of ileal pouch) and secondary ileostomy (SI, i.e. stoma created after pouch failure) and to evaluate factors associated with the development of CD of the neo-small intestine proximal to ileostomy. Methods: A total of 123 eligible patients were identified from our Pouch Center Registry (PI group, n = 57 and SI group, n = 66). Demographics, clinical features and outcomes (CD of the neo-small intestine, non-CD related strictures, requirement of CD-related medications use, ileostomy-associated hospitalization, ileostomy failure with stoma revision/relocation, and shortgut syndrome) were compared.
Abbreviations

CD
Crohn 
Introduction
Approximately 20-30% of patients with ulcerative colitis (UC) eventually require colectomy for medically refractory disease or colitisassociated neoplasia. While few patients may elect to have primary ileostomy (PI) after colectomy for a 'complete cure' for UC, the vast majority of patients would elect to have restorative proctocolectomy (RPC) with ileal pouch-anal anastomosis (IPAA). RPC/IPAA is the surgical treatment of choice for UC patients with medically refractory disease or colitis-associated neoplasia. [1] [2] [3] IPAA has been consistently shown to improve patients' health-related quality of life. On the other hand, the procedure is often associated with inflammatory and non-inflammatory adverse sequelae that affect the outcome of IPAA. Some of the adverse sequelae (including chronic antibiotic-refractory pouchitis, 4 Crohn's disease (CD) of the pouch, 5 and cuffitis 6 ) may lead to a permanent ileostomy. A few patients with permanent ileostomy after pouch failure may develop new diseased conditions in the neosmall bowel. In clinical practice of our subspecialty Pouchitis Center, we noticed that patients having total proctocolectomy (TPC) and end ileostomy (EI), i.e. primary ileostomy (PI), rarely develop de novo CD in the neo-small bowel. In contrast, the diseased neo-small bowel in those with secondary ileostomy (SI) due to pouch failure from CD of the pouch and other diseased pouch conditions, were more common. While the risk factors for the development of CD of the pouch after IPAA have been reported, 7, 8 little is known about the development of post-operative CD in the neo-small intestine after pouch failure of IPAA and permanent diverting ileostomy, i.e. SI. We hypothesized that CD of the neo-small intestine (CDNSI) in patients with TPC and PI or SI was a special disease and may be associated with certain risk factors. The aim of this study was to evaluate potential factors associated with the development of CDNSI to an ileostomy created for pouch failure in patients who had undergone IPAA.
Patients and methods
Study population
All eligible patients with UC who underwent TPC/IPAA and subsequent long-term/permanent ileostomy (the secondary ileostomy or SI) creation for a failed ileal pouch and those who underwent TPC/end ileostomy (the primary ileostomy or PI) were studied. The Cleveland Clinic Institutional Review Board (IRB) approved this study. A total of 123 consecutive, eligible patients from our Pouch Registry between January 2003 and December 2012 were included in this study, including 66 patients in the SI group and 57 patients in the PI group (Figure 1 ).
Inclusion and exclusion criteria
Inclusion criteria were patients with: (i) underlying IBD; (ii) TPC with primary or secondary EI; and (iii) a regular follow-up at our Pouch Center.
Exclusion criteria were patients with: (i) underlying familial adenomatous polyposis (FAP); and (ii) temporary diverting ileostomy, PI or SI; and other ostomy such as colostomy and continent ileostomy (i.e. Kock pouch).
Demographic and clinical variables
The following data were extracted from the data registry and charts: dates of birth, UC diagnosis, and IPAA/EI, smoking status, extraintestinal manifestations (EIMs) of inflammatory bowel diseases (IBD)-skin, eye, joint, and liver; pre-and post-operative medical therapies; post-operative complications (such as small bowel obstruction, stoma prolapse, enterocutaneous fistula); age at diagnosis of CDNSI; familial history of IBD; postoperative ileostomyassociated hospitalization; ileostomy failure with stoma revision or relocation; and short-gut syndrome.
Diagnosis of Crohn's disease of the neo-small intestine in stoma patients
The diagnosis of CDNSI was based on a combined assessment of clinical, endoscopic, histologic and radiographic features. The diagnosis of CDNSI was entertained if any of following conditions was present: (i) non-caseating, non-mucinous granulomas in the neosmall bowel or upper GI track; (ii) discreate ulcers and strictures of the neo-small bowel beyond 10cm from the stoma, in the absence of non-steroidal anti-inflammatory drug (NSAID) use (Figure 2 and Figure 3 ); (iii) newly developed entero-enteric fistulae or enterocutaneous fistulae with exclusion of surgical factors. If the diagnosis was in doubt, a diagnostic trial of corticosteroids or anti-tumor necrosis factor (TNF) agents was implemented. The diagnosis of CDNSI was considered if the patient had an endoscopic response to the therapy.
Outcome measurements
The primary outcome was the risk factors associated with the development of CD or a CD-like condition of the neo-small intestine, after the primary or secondary ileostomy. On a few occasions, we could not completely exclude a component of surgery-associated ischemic changes, which in many ways overlap with endoscopic, imaging and histologic findings of CD. In fact, the terms of CD of the pouch and Crohn's disease-like condition of the pouch have been used interchangeably in the setting of IPAA. 9 The secondary outcomes were other stoma-related complications, the use of CD medicine, and CD of the neo-small intestine-related hospitalization.
Statistical analysis
Continuous variables were dichotomized according to the median and interquartile range (IQR) or mean and standard deviation (SD). Categorical variables were compared with the use of chi-squared or Fisher's exact test. Variables, which were found to be predictive in the univariate analysis at a p < 0.10 level, were introduced into the Cox model for multivariate analysis. All hypothesis testing was twosided, with a p-value of <0.05 considered statistically significant.
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Relative risk (RR) was presented as mean estimate with a 95% confidence interval (CI).
Results
Patient demographics and clinical characteristics
Patient demographic and clinical characteristics, and details of surgical treatment for the 123 study patients with UC are shown in Table 1 . The median follow-up for the cohort was 5 (IQR: 2.0-12.0) years. A total of 18 pre-stoma factors were compared between the SI and PI groups. Younger age at diagnosis and surgery for UC, family history of IBD, extensive UC, toxic megacolon/fulminant colitis, preoperative symptom of severe diarrhea (more than 10 times per day), preoperative anti-TNF biological therapy (precolectomy), arthralgia/arthropathy, and staged pouch construction surgery were more common in patients who underwent SI after a failed pouch, than those in the primary ileostomy group (p < 0.05). There were no differences in smoking, body mass index, use of corticosteroid immunomodulators before precolectomy surgery, preoperative history of anemia/blood transfusion, duration from UC diagnosis to colectomy, and indication of colectomy (refractory UC vs. colitis-associated neoplasia) between the two groups (p > 0.05).
Causes of pouch failure leading to permanent ileostomy in the SI group
In the present study, there were a total of 66 patients who underwent secondary end ileostomy due to a failed pelvic pouch, including 34 patients (51.5%) having pouch excision surgery. The post-IPAA complications leading to the construction of a secondary ileostomy are listed in Table 2 . Pouch fistula (22.7%), chronic pouchitis (18.2%), ideopathic poor pouch function (15.2%), and strictures (13.6%) contributed for the majority of failed pouch surgery. Six patients (9.1%) of 66 had SI for CD of the pouch.
Comparison of outcomes between the primary and secondary ileostomy groups
We then compared outcomes of patients in the PI and SI groups. Of the 123 study patients, 35 (28.5%) developed CDNSI during the following-up period, including five cases (8.8%) in the PI group and 30 cases (45.5%) in the SI group (p < 0.001). Post-operative intestinal stricture was more commonly seen in the SI group (n = 36, 54.6%) than in the PI group (n = 7, 1.2%) (p < 0.01). The patients in the SI group experienced postoperative small bowel obstruction more frequently (48.5% vs. 8.8%) than those in the PI group (p < 0.001). A significantly greater number of patients in the SI group continued the treatment with corticosteroid, immunomodulator, or anti-TNF biologics after stoma creation; had a prolonged hospital stay, or readmission and surgery (re-resection/ stricturoplasty) than those in the PI group (p < 0.05). There were no statistical differences in stoma-associated complications, including parastomal hernia and stoma prolapse, between the two groups (p > 0.05). Patients in the SI group showed more risk of developing short-gut syndrome (4.5%) than those in the PI group (1.8%). There were six patients (9.1%) in the SI group who developed In the PI group, five patients underwent staged surgeries: four underwent laparotomy and/or peritoneal drainage for abscess in the first operation, and one had stoma relocation due to skin infection in the first month after his initial colectomy.
postoperative enterocutenous fistula, while those in the PI group numbered three (5.3%) ( Table 3) .
Risk factors for CD of the neo-small intestine
In the present study, there were 35 patients who developed CDNSI. Numbers of those patients in the two groups were shown in Figure 1 . CD of the pouch contributed partly to pouch failure after IPAA. Among those patients with CDNSI after IPAA, there were no statistical differences between patients with CD of the pouch and those in the non-CD of the pouch group (3/6 vs. 27/60, p > 0.05). In the SI group, 19 of 34 patients (63.3%) who underwent pouch resection surgery due to pouch failure, developed de novo CD in the neo-small intestine. Of 32 patients who underwent pouch salvage surgery, 11 patients (36.7%) had de novo CD. There was no difference in CDNSI between patients with pouch salvage surgery and those without (Table 4) . Table 5 shows a step-wise logistic regression model for the description of risk factors associated with CDNSI in patients with primary or secondary ileostomy. In multivariate analysis, the secondary ileostomy after failure of IPAA (OR, 8.23; 95% CI, 2.43-27.85), family history of IBD (OR, 9.14; 95% CI, 3.13-26.69), and preoperative history of weight loss (OR, 3.72; 95% CI, 1.23-11.21) were contributing factors for developing CD.
Discussion
It is generally believed that permanent end ileostomy following TPC for UC is curative. Since the introduction of restorative proctocolectomy with ileoanal pouch construction was performed in humans by Nils Kock in 1968, followed by the classic description of pelvic pouch by Parks and Nicholls in 1978, this operation has come to be considered as the procedure of choice for UC patients who require colectomy. 10 Despite the success story, 6% to 12% of patients will develop chronic pouch dysfunction and pouch failure requiring diversion with or without excision of the pouch. 11, 12 However, subsequent case reports documented patients who developed 'ileitis' in the ileostomy or proximal small bowel during the long term following-up. 13 The observation that histology of the inflamed terminal ileum in these cases suggested that 'prestomal ileitis' represents the development of CD.
14 CDNSI in UC patients after proctocolectomy is a relatively new disease entity, which was termed post-colectomy enteritis. There are scant published data with regards to potential factors associated with postoperative CD in the SI.
Despite excellent functional results and high patient satisfaction, inflammatory and non-inflammatory diseases can develop after IPAA, which adversely affect the outcome of IPAA and compromise patients' quality of life. These disease conditions of IPAA include pouchitis, CD of the pouch, cuffitis, and IPS. In clinical practice, approximately 5 to 10 percent of patients develop CD of the pouch. There is literature on risk factors for the development of CD of the pouch after IPAA. 5, 7, 8 In our previous study, CD of the pouch can present with three clinical phenotypes, that is, inflammatory, fibrostenotic, and fistulizing diseases. 7 Each of the clinical phenotypes is associated with different risk factors. Previous studies have shown that the risk factors for CD of the pouch (including a long duration of having a pouch, being an active smoker, 15 a preoperative diagnosis of indeterminate colitis, 16 family history of CD, 7 and seropositive anti-Saccharomyces cerevisiae (ASCA)-IgA). 17 While the established risk factors for the development of CD of the pouch after IPAA have been reported, the pathogenesis of CDNSI is unknown. The evidence concerning risk factors for CDNSI has not been studied. In this study, we found that patients who underwent SI after a failed pouch were more like to develop CDNSI and carry a worse clinical outcome than those in the PI group. Then it is hypothesized that CDNSI was associated with certain risk factors. This study is the first of its kind to evaluate and compare risk factors of CDNSI between patients with PI or SI. By logistic regression analysis, several factors were identified associated with de novo CD after TPC, including the presence of SI after failure of IPAA, family history of IBD, and a preoperative history of weight loss.
Making a firm diagnosis of CDNSI may be challenging, as there are no sensitive and specific markers. Only 10-12% of patients with known de novo CD had granulomas on mucosal biopsy in non-pouch patients. 18 Endoscopic features may provide additional diagnostic clues of de novo CD. 19 Radiographic evaluation is often needed to confirm the diagnosis and to delineate disease severity, disease extent and extraluminal complications. The diagnosis in our study was made by the consolidated results of radiography, endoscopy, pathology, and clinical manifestations. Of all 123 eligible cases in the present study, 35 patients developed CDNSI.
In our study, patients in the SI group after a failed pouch showed a worse clinical outcome than those in the PI group. Those patients 
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with CDNSI in the present study required re-treatment of IBD-related therapy for improving their clinical symptoms. We found that more patients in the SI group underwent postoperative continued medication use (corticosteroids, immunomodulators or anti-TNF biologics) for the treatment of clinical symptoms associated with de novo CD than those in the PI group. Frequently reported complaints included irritated peristomal skin, retracted stoma with stenosis, and high liquid stoma output. 20 Those patients with peristomal complications associated with de novo CD after ostomy surgery may often require surgical re-intervention for a revision or relocation of the stoma with or without additional small bowel resection. 21, 22 In the present study, a significantly greater proportion of patients in the SI group underwent ileostomy-associated hospitalization than those in PI group. There were 15 patients (22.7%) in the SI group who required surgical revision or relocation of the stoma, while only four cases in the PI group underwent additional surgery (p = 0.016).
Small bowel obstruction is a common postoperative complication of TPC with or without pouch surgery. 23 Although conservative management, including nasogastric suction and bowel rest, may prove effective for immediate treatment, most patients who experience obstruction ultimately require surgical intervention. For those who were difficult to treat with adhesiolysis, excisions of the small bowel involved were needed. As expected, more patients in the SI group developed short-gut syndrome due to multiple bowel surgeries than those in the PI group. The most serious outcome was the development of short-gut syndrome from multiple surgeries for small bowel diseases. Most of these clinical manifestations were led by stoma retraction and stricture associated with the development of CD. Our study showed that patients with SI were more likely to develop postoperative small bowel obstruction than those with PI ( p< 0.001). As a result, it was more common that patients in this group required prolonged hospital stay or readmission and surgery (re-resection/stricturoplasty) to improve clinical symptoms associated with de novo CD, than those with PI (p < 0.05). Of all the eligible patients in our study, four patients eventually developed short-gut syndrome after re-resection surgery, including three cases in the SI group.
The findings of our current studies have several clinical implications. During pre-TPC/IPAA counseling with a UC patient requiring TPC, the outcomes and sequelae of TPC/permanent ileostomy (i.e. PI) and RPC/IPAA should be explained. CDNSI can occur in both PI and SI, although the frequency in the former is less. We believe that almost all UC patients requiring colectomy deserve a chance of having an ileal pouch. They must, however, be carefully counseled and informed that RPC is associated both with a higher rate of long-term complications, including the risk of de novo CD and pouch failure and even conversion to permanent EI. The results of the current study suggest that RPC, if it results in pouch failure and secondary ileostomy, may be associated with a higher risk for CDNSI than those with TPC and primary end ileostomy. Therefore, the threshold for permanent EI for patients with pouch failure may be further raised. For example, a dysfunctional pouch due to mechanical or structural diseases (such as afferent or efferent limb syndrome, twisted pouch, or chronic antibiotic-refractory pouchitis) may be treated using pouch revision surgery. 24, 25 For patients with pouch strictures, periodic endoscopic therapy or surgical stricturoplasty may help reduce the risk for pouch-diverting surgery. 26 For patients with CD of the pouch, therapy with anti-TNF agents has been shown to be beneficial. 27 In patients who have had a failed ileal pouch who also have SI, close disease monitoring with periodic ileoscopy via stoma is advocated, particularly in those with risk factors for CDNSI, such as the presence of a family history of IBD and a pre-diversion diagnosis of CD of the pouch.
There are limitations to our study. First, there might have been referral bias, since all the patients in the current study were seen in the setting of a subspecialty Pouchitis Clinic where patients with de novo CD were diagnosed and managed by IBD specialists and colorectal surgeons, which might also have introduced a selection bias. Second, the sample size is not adequate for extensive multivariable analyses, yet this study has the largest number of patients reported in the literature. Third, the report has been hampered by the retrospective design and suboptimal patient follow-up in some cases. For the past decade, our group has attempted to incorporate serological (such as anti-Saccharomyces cervisiae 28 ) and genetic markers (such as NOD2/CARD15 9 ) to confirm the diagnosis of CD of the pouch. The accuracy of those serological and genetic markers for the diagnosis and differential diagnosis of ileal pouch disorders has been disappointing. Therefore, we have not incorporated those markers into our routine clinical practice. We believe that CD of the pouch or CD of the neo-small intestine may a variant of CD, each with its own etiologies, pathogenetic pathways, disease phenotypes, and prognoses. Nonetheless, we believe that the results of our study provide useful information for patients and clinicians in decision-making regarding appropriate surgery at the time of colectomy (i.e. the choice between permanent PI and IPAA) and management of refractory pouch disorders leading to pouch failure and SI.
In conclusion, CD of the neo-small intestine in stoma patients was associated with the presence of SI, family history of IBD, and pre-diversion
